Developing treatments for rhodopsin-related dominant retinitis pigmentosa
<p>Mutations in the rhodopsin gene are one of the most common causes of autosomal dominant retinitis pigmentosa (ADRP) and there is at present no treatment available. In this thesis, three potential treatments were developed and tested in a R<em>ho</em><sup>P23H/+</sup>...
Autor principal: | Orlans, H |
---|---|
Outros Autores: | MacLaren, R |
Formato: | Thesis |
Idioma: | English |
Publicado em: |
2019
|
Assuntos: |
Registos relacionados
-
Nonretinoid chaperones improve rhodopsin homeostasis in a mouse model of retinitis pigmentosa
Por: Abhishek Vats, et al.
Publicado em: (2022-05-01) -
TBC1D32 variants disrupt retinal ciliogenesis and cause retinitis pigmentosa
Por: Béatrice Bocquet, et al.
Publicado em: (2023-11-01) -
Nrf2 overexpression rescues the RPE in mouse models of retinitis pigmentosa
Por: David M. Wu, et al.
Publicado em: (2021-01-01) -
Adeno-associated virus mediated rhodopsin delivery in preventing secondary cone degeneration in rhodopsin knockout mice
Por: Dauletbekov, D
Publicado em: (2016) -
Aggregation of rhodopsin mutants in mouse models of autosomal dominant retinitis pigmentosa
Por: Sreelakshmi Vasudevan, et al.
Publicado em: (2024-02-01)